Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
International Journal of Clinical Pharmacy|May 17, 2013
Antihypertensive use before and after initiation of fixed-dose combination products in Australia: a retrospective studySvetla Gadzhanova, Jenni Ilomäki, Elizabeth E Roughead
Drugs & Aging|November 27, 2012
COX-2 inhibitor and non-selective NSAID use in those at increased risk of NSAID-related adverse events: a retrospective database studySvetla Gadzhanova, Jenni Ilomäki, Elizabeth E Roughead
Current Opinion in Psychiatry|January 24, 2020
Using clinical registries, administrative data and electronic medical records to improve medication safety and effectiveness in dementiaJenni Ilomäki, Edward Chia-Cheng Lai, J Simon Bell
Addiction (Abingdon, England)|December 10, 2019
Transition to high-dose or strong opioids: a population-based study of people initiating opioids in AustraliaSamanta Lalic, Natasa Gisev, J Simon Bell, et al.
Therapeutic Advances in Drug Safety|April 7, 2018
Spontaneously reported adverse drug events related to tapentadol and oxycodone/naloxone in AustraliaCarmen Abeyaratne, Samanta Lalic, J Simon Bell, et al.
Plos One|June 22, 2012
Alcohol consumption and dietary patterns: the FinDrink studyTimothy O Fawehinmi, Jenni Ilomäki, Sari Voutilainen, et al.
European Journal of Clinical Pharmacology|July 29, 2017
The representativeness of direct oral anticoagulant clinical trials to hospitalized patients with atrial fibrillationLaura Fanning, Jenni Ilomäki, J Simon Bell, et al.
The Annals of Pharmacotherapy|September 8, 2011
Heavy drinking and use of sedative or anxiolytic drugs among aging men: an 11-year follow-up of the FinDrink studyJenni Ilomäki, J Simon Bell, Jussi Kauhanen, et al.
Health Science Reports|November 8, 2024
Are People Living With Dementia Receiving High Intensity Statin Therapy After Stroke? A Population-Based Cohort StudyLeonie Picton, Johnson George, J Simon Bell, et al.
BMC Medical Research Methodology|June 3, 2014
The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: a simulation studyNicole L Pratt, Jenni Ilomäki, Chris Raymond, et al.
Pageof 11